The name of this project is Pymaceuticals.
In Pymaceuticals study, 249 mice who were identified with SCC tumors received treatment with a range of drug regimens. Over the course of 45 days, tumor development was observed and measured.
We compare 4 treatment Capomulin, Infubinol, Ketapril, and Placebo.
